» Articles » PMID: 34807501

Deep Learning-based Auto-segmentation of Clinical Target Volumes for Radiotherapy Treatment of Cervical Cancer

Overview
Date 2021 Nov 22
PMID 34807501
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Because radiotherapy is indispensible for treating cervical cancer, it is critical to accurately and efficiently delineate the radiation targets. We evaluated a deep learning (DL)-based auto-segmentation algorithm for automatic contouring of clinical target volumes (CTVs) in cervical cancers.

Methods: Computed tomography (CT) datasets from 535 cervical cancers treated with definitive or postoperative radiotherapy were collected. A DL tool based on VB-Net was developed to delineate CTVs of the pelvic lymph drainage area (dCTV1) and parametrial area (dCTV2) in the definitive radiotherapy group. The training/validation/test number is 157/20/23. CTV of the pelvic lymph drainage area (pCTV1) was delineated in the postoperative radiotherapy group. The training/validation/test number is 272/30/33. Dice similarity coefficient (DSC), mean surface distance (MSD), and Hausdorff distance (HD) were used to evaluate the contouring accuracy. Contouring times were recorded for efficiency comparison.

Results: The mean DSC, MSD, and HD values for our DL-based tool were 0.88/1.32 mm/21.60 mm for dCTV1, 0.70/2.42 mm/22.44 mm for dCTV2, and 0.86/1.15 mm/20.78 mm for pCTV1. Only minor modifications were needed for 63.5% of auto-segmentations to meet the clinical requirements. The contouring accuracy of the DL-based tool was comparable to that of senior radiation oncologists and was superior to that of junior/intermediate radiation oncologists. Additionally, DL assistance improved the performance of junior radiation oncologists for dCTV2 and pCTV1 contouring (mean DSC increases: 0.20 for dCTV2, 0.03 for pCTV1; mean contouring time decrease: 9.8 min for dCTV2, 28.9 min for pCTV1).

Conclusions: DL-based auto-segmentation improves CTV contouring accuracy, reduces contouring time, and improves clinical efficiency for treating cervical cancer.

Citing Articles

A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer.

Bolten J, Neugebauer D, Grott C, Weykamp F, Ristau J, Mende S Clin Transl Radiat Oncol. 2025; 52:100933.

PMID: 40028424 PMC: 11871478. DOI: 10.1016/j.ctro.2025.100933.


Deep learning based ultra-low dose fan-beam computed tomography image enhancement algorithm: Feasibility study in image quality for radiotherapy.

Jiang H, Qin S, Jia L, Wei Z, Xiong W, Xu W J Appl Clin Med Phys. 2024; 25(12):e14560.

PMID: 39540681 PMC: 11633815. DOI: 10.1002/acm2.14560.


Automatic delineation of cervical cancer target volumes in small samples based on multi-decoder and semi-supervised learning and clinical application.

Peng H, Liu T, Li P, Yang F, Luo X, Sun X Sci Rep. 2024; 14(1):26937.

PMID: 39505991 PMC: 11542092. DOI: 10.1038/s41598-024-78424-0.


First Application of Demand-Triggered Online Adaptive Radiotherapy in the Treatment of Cervical Cancer: A Clinical Report.

Ma C, Zhou J Cureus. 2024; 16(9):e69703.

PMID: 39429366 PMC: 11490271. DOI: 10.7759/cureus.69703.


Clinical target volume (CTV) automatic delineation using deep learning network for cervical cancer radiotherapy: A study with external validation.

Wu Z, Wang D, Xu C, Peng S, Deng L, Liu M J Appl Clin Med Phys. 2024; 26(1):e14553.

PMID: 39401180 PMC: 11712972. DOI: 10.1002/acm2.14553.


References
1.
Wong J, Fong A, McVicar N, Smith S, Giambattista J, Wells D . Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning. Radiother Oncol. 2019; 144:152-158. DOI: 10.1016/j.radonc.2019.10.019. View

2.
Meng L, Tian Y, Bu S . Liver tumor segmentation based on 3D convolutional neural network with dual scale. J Appl Clin Med Phys. 2019; 21(1):144-157. PMC: 6964770. DOI: 10.1002/acm2.12784. View

3.
Bhatla N, Aoki D, Sharma D, Sankaranarayanan R . Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018; 143 Suppl 2:22-36. DOI: 10.1002/ijgo.12611. View

4.
Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

5.
Hong T, Tome W, Harari P . Heterogeneity in head and neck IMRT target design and clinical practice. Radiother Oncol. 2012; 103(1):92-8. PMC: 3694728. DOI: 10.1016/j.radonc.2012.02.010. View